<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Buring, J.E.</title>
    <link>http://repub.eur.nl/res/aut/40769/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies (Article)</title>
      <link>http://repub.eur.nl/res/pub/28342/</link>
      <pubDate>2010-12-01T00:00:00Z</pubDate>
      <description>To identify loci for age at menarche, we performed a meta-analysis of 32 genome-wide association studies in 87,802 women of European descent, with replication in up to 14,731 women. In addition to the known loci at LIN28B (P = 5.4 × 10 -60) and 9q31.2 (P = 2.2 × 10 -33), we identified 30 new menarche loci (all P &lt; 5 × 10 -8) and found suggestive evidence for a further 10 loci (P &lt; 1.9 × 10 -6). The new loci included four previously associated with body mass index (in or near FTO, SEC16B, TRA2B and TMEM18), three in or near other genes implicated in energy homeostasis (BSX, CRTC1 and MCHR2) and three in or near genes implicated in hormonal regulation (INHBA, PCSK2 and RXRG). Ingenuity and gene-set enrichment pathway analyses identified coenzyme A and fatty acid biosynthesis as biological processes related to menarche timing. </description>
    </item> <item>
      <title>Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: A prospective, nested case-control study (Article)</title>
      <link>http://repub.eur.nl/res/pub/32365/</link>
      <pubDate>2008-01-01T00:00:00Z</pubDate>
      <description>BACKGROUND: Heat shock protein 27 (HSP27) has been hypothesized to be a potential biomarker of atherothrombosis. However, no prospective studies have yet been performed to investigate the association between HSP27 plasma concentration and incident cardiovascular events among initially healthy individuals. METHODS: We evaluated plasma concentrations of HSP27 at baseline among 255 initially healthy participants in the Women's Health Study who subsequently developed myocardial infarction, ischemic stroke, or cardiovascular death during a follow-up period of up to 5.9 years and among an equal number of women matched for age and smoking but who remained free of cardiovascular disease over the same time period. RESULTS: Overall, HSP27 plasma concentrations were inversely associated with age (Spearman correlation coefficient r = -0.258, P &lt;0.001), but not with other established cardiovascular risk factors. Conditional logistic regression analysis showed no significant association of baseline HSP27 plasma concentration with future cardiovascular disease; the odds ratio for upper vs lower tertile of HSP27 concentration at baseline was 0.99 (95% CI 0.62-1.57, P for trend = 0.99). CONCLUSION: In this prospective study of initially healthy women, baseline HSP27 plasma concentration was not associated with incident cardiovascular events. </description>
    </item>
  </channel>
</rss>